927
Views
21
CrossRef citations to date
0
Altmetric
Research Paper

LncRNA NNT-AS1 promote glioma cell proliferation and metastases through miR-494-3p/PRMT1 axis

, , , , , , & show all
Pages 1621-1631 | Received 22 Oct 2019, Accepted 18 Mar 2020, Published online: 18 May 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (20)

Haibo Liu, Jie Zhang, Jiamin Li, Xiaoying Cao, Kai Yu, Xun Xia, Zongxi Li & Fengbo Wang. (2024) LncRNA PSMB8-AS1 increases glioma malignancy via the miR-382-3p/BCAT1 axis. Translational Oncology 39, pages 101806.
Crossref
Kewei Chang, Dan Gao, Jidong Yan, Liyan Lin, Tingting Cui & Shemin Lu. (2023) Critical Roles of Protein Arginine Methylation in the Central Nervous System. Molecular Neurobiology.
Crossref
Akram M Eraky. (2023) Advances in Brain Metastases Diagnosis: Non-coding RNAs As Potential Biomarkers. Cureus.
Crossref
Maria‐Alexandra Papadimitriou, Konstantina Panoutsopoulou, Katerina‐Marina Pilala, Andreas Scorilas & Margaritis Avgeris. (2022) Epi‐miRNAs : Modern mediators of methylation status in human cancers . WIREs RNA 14:2.
Crossref
Xia Wu, Lvmeng Song, Xiangrong Chen, Yalan Zhang, Shun Li & Xiaoping Tang. (2022) Long non-coding RNA LUCAT1 regulates the RAS pathway to promote the proliferation and invasion of malignant glioma cells through ABCB1. Experimental Cell Research 421:2, pages 113390.
Crossref
Nada M. El-Sheikh, Ahmed I. Abulsoud, Eman F. Wasfey & Nadia M. Hamdy. (2022) Insights on the potential oncogenic impact of long non-coding RNA nicotinamide nucleotide transhydrogenase antisense RNA 1 in different cancer types; integrating pathway(s) and clinical outcome(s) association. Pathology - Research and Practice 240, pages 154183.
Crossref
Soudeh Ghafouri-Fard, Sepideh Dashti, Leila Gholami, Elham Badrlou, Saba Sadeghpour, Bashdar Mahmud Hussen, Hazha Jamal Hidayat, Naghme Nazer, Mahdi Shadnoush, Arezou Sayad & Noormohammad Arefian. (2022) Expression analysis of Wnt signaling pathway related lncRNAs in periodontitis: A pilot case-control study. Human Gene 33, pages 201069.
Crossref
Fan Jiang, Zheng Zhan, Yanbo Yang, Guangjie Liu, Song Liu, Jingyu Gu, Zhouqing Chen, Zhong Wang & Gang Chen. (2022) Construction and Validation of a Necroptosis-Related lncRNA Signature in Prognosis and Immune Microenvironment for Glioma. Journal of Oncology 2022, pages 1-17.
Crossref
Mirte Scheper, Alessia Romagnolo, Zein Mersini Besharat, Anand M. Iyer, Romina Moavero, Christoph Hertzberg, Bernhard Weschke, Kate Riney, Martha Feucht, Theresa Scholl, Borivoj Petrak, Alice Maulisova, Rima Nabbout, Anna C. Jansen, Floor E. Jansen, Lieven Lagae, Malgorzata Urbanska, Elisabetta Ferretti, Aleksandra Tempes, Magdalena Blazejczyk, Jacek Jaworski, David J. Kwiatkowski, Sergiusz Jozwiak, Katarzyna Kotulska, Krzysztof Sadowski, Julita Borkowska, Paolo Curatolo, James D. Mills & Eleonora Aronica. (2022) miRNAs and isomiRs: Serum-Based Biomarkers for the Development of Intellectual Disability and Autism Spectrum Disorder in Tuberous Sclerosis Complex. Biomedicines 10:8, pages 1838.
Crossref
Jing Zhang, Bo Wang, Hong-Xia Wang, Fan-Ming Kong, Xiao-Jiang Li & Ying-Jie Jia. (2022) Long noncoding RNA NNT-AS1 inhibits IL-17-induced proliferation, migration, and invasion of gastric cancer cells by regulating miR-518a-3p. World Chinese Journal of Digestology 30:13, pages 571-578.
Crossref
Kun Liu, Hong Chen, Yuanyuan Wang, Liping Jiang & Yi Li. (2022) Evolving Insights Into the Biological Function and Clinical Significance of Long Noncoding RNA in Glioblastoma. Frontiers in Cell and Developmental Biology 10.
Crossref
Janet A. GrimesKelsey R. RobinsonAnna-Claire M. BullingtonJennifer M. Schmiedt. (2021) Identification of serum microRNAs with differential expression between dogs with splenic masses and healthy dogs with histologically normal spleens. American Journal of Veterinary Research 82:8, pages 659-666.
Crossref
Jin Zou, Wei Shen, Yu Zhang & Shibo Ying. 2021. Post-Translational Modifications in Cellular Functions and Diseases. Post-Translational Modifications in Cellular Functions and Diseases.
Lei Yu, Wei Zhang, Peng Wang, Qi Zhang, Aihua Cong, Xiuyuan Yang & Kai Sang. (2021) LncRNA SNHG11 aggravates cell proliferation and migration in triple‑negative breast cancer via sponging miR‑2355‑5p and targeting CBX5. Experimental and Therapeutic Medicine 22:2.
Crossref
Liang Liu, Xiaojian Li, Yan Shi & Hua Chen. (2021) Long noncoding RNA DLGAP1-AS1 promotes the progression of glioma by regulating the miR-1297/EZH2 axis. Aging 13:8, pages 12129-12142.
Crossref
Liang Cen, Ruochen Liu, Wei Liu, Qianqian Li & Hongjuan Cui. (2021) Competing Endogenous RNA Networks in Glioma. Frontiers in Genetics 12.
Crossref
Jean-Paul Bryant, John Heiss & Yeshavanth Kumar Banasavadi-Siddegowda. (2021) Arginine Methylation in Brain Tumors: Tumor Biology and Therapeutic Strategies. Cells 10:1, pages 124.
Crossref
Haitao Xu, Jing Miao, Shuai Liu, Hongjian Liu, Lianguo Zhang & Qingguang Zhang. (2021) Long non-coding RNA KCNQ1 overlapping transcript 1 promotes the progression of esophageal squamous cell carcinoma by adsorbing microRNA-133b. Clinics 76, pages e2175.
Crossref
Qiuli Liu, Po Gao, Qingling Li, Chao Xu, Kai Qu & Jie Zhang. (2021) Long non-coding RNA SNHG16 as a potential biomarker in hepatocellular carcinoma. Medicine 100:36, pages e27178.
Crossref
Cong Zhou & Shiwei Duan. (2020) The Role of Long Non-Coding RNA NNT-AS1 in Neoplastic Disease. Cancers 12:11, pages 3086.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.